|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 750 9th Street, NW |
Address2 | Suite 600 |
City | WASHINGTON |
State | DC |
Zip Code | 20001 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 14267-12
|
||||||||
|
6. House ID# 326350000
|
TYPE OF REPORT | 8. Year | 2020 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Katie Tenoever |
Date | 11/16/2020 4:50:10 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Monitored Congressional Proposals concerning health price transparency.
H.R. 1384 - "Medicare For All Act of 2019", S.1129 - "A bill to establish a Medicare-for-all national health insurance program" - Oppose legislation to impose single payer health care delivery.
H.R. 2085/ S.1033 "Consumer Health Options and Insurance Competition Enhancement Act (CHOICE) Act", H.R. 2000/S.981 - "Medicare-X Choice Act of 2019" - Oppose legislation to impose a Medicare public option.
H.R. 728/S.1399 - "Title VIII Nursing Workforce Re-authorization Act of 2019" - Support legislation to provide loan repayment for nurses to practice in any care setting.
S. 1895 - "Lower Health Care Costs Act" - Support protecting patients from surprise billing and oppose government rate setting. Advocated for appropriate transparency and contracting flexibility.
S.1531 "Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019", H.R. 3630 "No Surprises Act", H.R. 3502 "Protecting People From Surprise Medical Bills Act", H.R. 5800 Ban Surprise Billing Act, H.R. 5826 "Consumer Protections Against Surprise Medical Bills Act of 2020" - Advocate to protect patients from surprise billing and oppose government rate setting.
H.R. 2328 "Community Health Investment, Modernization, and Excellence Act of 2019", H.R. 748 "Coronavirus Aid, Relief, and Economic Security Act" - Support re-authorization of National Quality Forum.
H.R. 3417 "Beneficiary Education Tools, Telehealth, and Extenders Reauthorization Act of 2019" - Supported legislation.
H.R. 748 Coronavirus Aid, Relief, and Economic Security (CARES) Act, H.R. 6837/ S. 3750 "Medicare Accelerated and Advance Payments Improvement Act of 2020", H.R. 266 "Paycheck Protection Program and Health Care Enhancement Act" - Advocated in support of funding and programs for hospitals and post-acute care providers to respond to COVID-19
H.R. 6800 "Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act" - Support expanded access and affordability of COBRA and other health insurance options
H.R. 6365/ S. 3559 "Immediate Relief for Rural Facilities and Providers Act of 2020" - Support expansion of access to telehealth programs for tax paying rural hospitals
H.R. 7059 "Coronavirus Provider Protection Act" - Evaluated and advocated for improvements to legislation
Liability Protections - Develop proposal to protect hospitals, healthcare professionals and facilities from liability due to COVID-19
Provider Relief Fund Taxability - Support technical corrections to Provider Relief Fund to ensure funds received are not taxable
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Charles |
Kahn |
|
|
|
Steve |
Speil |
|
|
|
Jonathan |
Jagoda |
|
|
|
Patrick |
Velliky |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R. 3062/S. 2860 - "Patient Access to Higher Quality Health Care Act of 2019" - Oppose efforts to repeal certain provisions relating to the Medicare exception to the prohibition on certain physician referrals for hospitals.
Bad Debt Payments to Hospitals - Oppose effort to lower bad debt payments to hospitals for Medicare beneficiaries who do not pay their cost-sharing for treatments provided by the hospital.
H.R. 2552 - "Protecting Local Access to Care for Everyone (PLACE) Act" - Support legislation to prevent site neutral cuts.
H.R. 1763/ S. 348 - "Resident Physician Shortage Reduction Act of 2019", H.R. 3414/S. 2892 - Opioid Workforce Act - Support GME legislation to reduce resident physician shortage.
Support access to affordable prescription drugs.
H.R. 3107 - "Improving Seniors' Timely Access to Care Act" - Support legislation that streamlines and standardizes prior authorization under the Medicare Advantage program.
Sought moratorium on proposed Medicaid Fiscal Accountability Regulation
H.R. 748 Coronavirus Aid, Relief, and Economic Security (CARES) Act - Advocated in support of funding and programs for hospitals and post-acute care providers to respond to COVID-19
H.R. 6800 Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act - Supported legislation
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Charles |
Kahn |
|
|
|
Steve |
Speil |
|
|
|
Jonathan |
Jagoda |
|
|
|
Patrick |
Velliky |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code COM
16. Specific lobbying issues
H.R. 6474 "Healthcare Broadband Expansion During COVID-19 Act" - Support. Seek expansion of eligibility criteria for legislation and FCC COVID-19 Telehealth Program
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Charles |
Kahn |
|
|
|
Steve |
Speil |
|
|
|
Jonathan |
Jagoda |
|
|
|
Patrick |
Velliky |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code IMM
16. Specific lobbying issues
H.R. 6788/ S. 3599 "Healthcare Workforce Resilience Act" - Support reclaiming unused J-Visas to ensure availability of qualified medical personnel
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Charles |
Kahn |
|
|
|
Steve |
Speil |
|
|
|
Jonathan |
Jagoda |
|
|
|
Patrick |
Velliky |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |